The Protective Effect of Apocynin on Cyclosporine A-Induced Hypertension and Nephrotoxicity in Rats

Journal of Cellular Biochemistry

Volumn 116, Issue 9, 2015, Pages 1848-1856

  Ciarcia, Roberto ^a   Damiano, Sara ^a   Florio, Alessia ^a   Spagnuolo, Manuela ^b   Zacchia, Enza ^b   Squillacioti, Caterina ^a   Mirabella, Nicola ^a   Florio, Salvatore ^a   Pagnini, Ugo ^a   Garofano, Tiziana ^c   Polito, Maria Sole ^d   Capasso, Giovambattista ^b   Giordano, Antonio ^d,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c AORN Ospedale dei Colli   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e Temple University   (United States)

Author keywords

APOCYNIN; CYCLOSPORINE A; NITRIC OXIDE; REACTIVE OXYGEN SPECIES

Indexed keywords

APOCYNIN; CYCLOSPORIN A; FIBRONECTIN; NITRIC OXIDE; SUPEROXIDE; ACETOPHENONE DERIVATIVE; CYCLOSPORIN; ENZYME INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HYPERTENSION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; RENAL PROTECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; KIDNEY DISEASES; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ACETOPHENONES; ANIMALS; BLOOD PRESSURE; CYCLOSPORINE; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HYPERTENSION; KIDNEY DISEASES; MALE; NADPH OXIDASE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84937460073     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25140     Document Type: Article

References (33)

1. Barros EJ, Boim MA, Ajzen H, Ramos OL, Schor N,. 1987. Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 32: 19-25.
2. Blough NV, Zafiriou OC,. 1985. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem 24 (22): 3502-3504.
3. Capasso G, Di Gennaro CI, Della Ragione F, Manna C, Ciarcia R, Florio S, Perna A, Pollastro RM, Damiano S, Mazzoni O, Galletti P, Zappia V,. 2008. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant 23 (4): 1186-1195.
4. Carter WO, Narayanan PK, Robinson JP,. 1994. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55: 253-258.
5. Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM, Edwards BS,. 1992. The sodium retaining effects of cyclosporine. Kidney Int 41 (6): 1599-1605.
6. Colombo D, Ammirati E,. 2011. Cyclosporine in transplantation-A history of converging timelines. J Biol Regul Homeost Agents 25 (4): 493-504.
7. Damiano S, Ciarcia R, Montagnaro S, Pagnini U, Garofano T, Capasso G, Florio S, Giordano A,. 2015. Prevention of Nephrotoxicity Induced by Cyclosporine-A: Role of Antioxidants. J Cell Biochem 116: 364-369.
8. Damiano S, Trepiccione F, Ciarcia R, Scanni R, Spagnuolo M, Manco L, Borrelli A, Capasso C, Mancini R, Schiattarella A, Iervolino A, Zacchia E, Bata-Csere A, Florio S, Anastasio P, Pollastro R, Mancini A, Capasso G,. 2013. A new recombinant MnSOD prevents the cyclosporine A-induced renal impairment. Nephrol Dial Transplant 28 (8): 2066-2072.
9. Fink B, Laude K, McCann L, Doughan A, Harrison DG, Dikalov S,. 2004. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol 287: C895-C902.
10. Forstermann U,. 2010. Nitric oxide and oxidative stress in vascular disease. Pflügers Archiv 459 (6): 923-939.
11. Galletti P, Di Gennaro CI, Migliardi V, Indaco S, Della Ragione F, Chiodini P, Capasso G, Zappia V,. 2005. Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant 20 (8): 1551-1558.
12. Gharaee-Kermani M, Wiggins R, Wolber F, Goyal M, Phan SH,. 1996. Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol 148 (3): 961-967.
13. Gryglewski RJ, Palmer RMJ, Moncada S,. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 (6061): 454-456.
14. Johnson DK, Schillinger KJ, Kwait DM, McNamara EJ, Ishmael F, O'Donnell RW, Chang MM, Hogg MG, Dordick JS, Santhanam L, Ziegler LM, Holland JA,. 2002. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 9 (3): 191-203.
15. Krauskopf A, Buetler TM, Nguyen NS, Macé K, Ruegg UT,. 2002. Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450. Br J Pharmacol 135: 977-986.
16. Lassila M,. 2002. Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab 3: 61-71.
17. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, Perez de Lema, Lamas M, Rodriguez- S, Puyol D,. 1988. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124: 447-454.
18. Lorenz JN1, Gruenstein E,. 1999. A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am J Physiol 276 (1 Pt 2): F172-F177.
19. Magnasco A, Rossi A, Catarsi P, Gusmano R, Ginevri F, Perfumo F, Ghiggeri GM,. 2008. Cyclosporin and organ specific toxicity: Clinical aspects, pharmacogenetics and perspectives. Curr Clin Pharmacol 3 (3): 166-173.
20. Montagnino G, Banfi G, Campise MR, Passerini P, Aroldi A, Cesana BM, Ponticelli C,. 2004. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation. Nephrol Dial Transplant 19: 2622-2629.
21. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. 2003. The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333.
22. Nishiyama A, Kobori H, Fukui T, Zhang GX, Yao L, Rahman M, Hitomi H, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y,. 2003. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 42 (4): 754-760.
23. Panico C, Luo Z, Damiano S, Artigiano F, Gill P, Welch WJ,. 2009. Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3. Hypertension 54 (6): 1291-1297.
24. Radeke HH, Cross AR, Hancock JT, Jones OT, Nakamura M, Kaever V, Resch K,. 1991. Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem 266 (31): 21025-21029.
25. Robson DC, Burton GG,. 2003. Cyclosporin: Applications in small animal dermatology. Vet Dermatol 14 (1): 1-9.
26. Ryffel B, Wilson J, Maurer R, Gudat F, Mihatsch MJ,. 1986. Problems of cyclosporine localization in the renal tissue. Clin Nephrol 25 (1): S34-S36.
27. Selemidis S, Sobey CG, Wingler K, Schmidt HW, Drummond GR,. 2008. NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120 (3): 254-291.
28. Serini G, Bochaton-Piallat M, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G,. 1998. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 142 (3): 873-881.
29. Settaf A, Gugenheim J, Lahlou MK, Gigou M, Capron-Laudereau M, Charpentier B, Reynes M, Lokiec F, Bismuth H,. 1989. Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat. J Chir 126 (8-9): 431-437.
30. Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ,. 1993. Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int 43 (3): 615-622.
31. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, Wilcox CS,. 2003. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14 (11): 2783-2789.
32. Wang T,. 1997. Nitric oxide regulates HCO3- and Na+ transport by cGMP-mediated mechanism in the kidney proximal tube. Am J Physiol 272: F242.
33. Wilcox CS,. 2005. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension. Am J Physiol Regul Integr Comp hysiol 289 (4): R913-R935.